Covid-19 treatment: Cipla, Hetero Lab get nod to manufacture and sell Remdesivir

Cipla, Hetero, and Jubilant Lifesciences have signed voluntary licensing agreements with Gilead.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/36wheNw
via IFTTT